Report ID: 10078307 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
Global Medical Marijuana Industry was valued at USD 9.01 Billion in the year 2017. Global Medical marijuana Industry is further estimated to grow at a CAGR of 16.91 % from 2019 to reach USD 32.40 Billion by the year 2025. North America region holds the highest Industry share in 2017 and Europe Industry is considered as the fastest growing Industry in the forecasted period due to growing demand in the healthcare industry and technological advancements. At a country level, U.S & Canada is projected to grow strongly in the coming years.
Major market players in the Medical Marijuana Industry are Canopy Growth Co., GW Pharmaceuticals PLC, Medical Marijuana Inc., United Cannabis Co, Cannabis Sativa Inc., GreenGro Technologies, Aurora Cannabis, United Cannabis Corp, Cara Therapeutics, GBSciences Inc., and brief overview of 10 companies is also provided in the report. Better global reach at an operational level is the main reason the key players are holding substantial Industry share. Rising research and development expenses to satisfy the changing demands of end users, new product launches and organic growth strategies were few techniques adopted by various manufacturers in last 5 years.
SWOT Analysis of Medical Marijuana Industry:
Strength:
The expansion of marijuana legalization in the U.S.
Weakness:
The stigma of marijuana in society
Lack of federal support
Opportunities:
Cannabis as healthcare treatment
Threats:
Legal Issues
The segmentation are done on the basis of Type of marijuana, by chemical component, by application, by end-use and by region. On the basis of Product Type, the Sativa segment is expected to hold the highest Industry share during the forecast period due to growing awareness and high demand. The segmentation done on the basis of Chemical Component the Tetrahydrocannabinol (THC) segment is expected to hold the highest Industry share.
Medical Marijuana Industry Segmentation
By Application
• Cancer
• Arthritis
• Alzheimer’s
• Pain Management
• Multiple Sclerosis
• Others
By End-User
• Hospitality
• Pharmaceutical Industry
• Research and Development Centers
By Chemical Component
• Tetrahydrocannabinol (THC)
• Cannabidiol (CBD)
• Hybrid (Combination of THC & CBD)
By Product Type
• Sativa
• Indica
• Hybrid
By Region
North America
• USA
• Canada
Europe
• Germany
• U.K.
• France
• Italy
• Rest of Europe
APAC
• China
• India
• Japan
• Rest of Asia-Pacific
RoW
• Latin America
• Middle East & Africa
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
Report ID: 10078307 |
Published Date: 21 Oct 2022 |
Report Format: |
Delivery Timeline: 48-72 Business Hours
